Global Continuous Glucose Monitoring Market Segmentation Analysis Report 2021-2026 | Global Continuous Glucose Monitoring Industry Analysis on Size, Share, Growth, Trends, Demand, Competitive Analysis, and Forecast Report 2021-2026

Published: September 2020  |  Report ID:DRR12  | Pages: 150

Continuous Glucose Monitoring Market Growth, Size and Forecast (2021-2026):

Global Continuous Glucose Monitoring Market size was worth USD 4.2 billion in 2021 and is anticipated to reach a value of USD 8.7 billion in 2026, developed at a CAGR of 22% between 2021 to 2026.

Continuous Glucose Monitoring Market is segmented by Component into Transmitters & Receivers, Sensors, Insulin Pumps, by End-Use into Hospitals, Homecare Diagnostics.

Growth in Asia Pacific Region:

According to our research analysis done by the Data Research Reports, Asia Pacific region is expected to grow at a highest CAGR of 27% during the assessment year (2021-2026).

Recent Developments in Continuous Glucose Monitoring Market:

S.No

Year

Recent Development/Acquisition/ Agreements

1

In March 2020

DexCom collaborated with Welldoc

2

In Feb 2020

Abbott came into partnership with Insulet

3

In Feb 2020

DexCom entered into an agreement with Insulet Corporation

4

In Feb 2020

Senseonics Holdings entered into an agreement with Companion Medical

5

In December 2019

Medtronic acquired Klue

6

In July 2017

Roche acquired mySugr GmbH

 

Continuous Glucose Monitoring Market Segmentation Analysis:

By Component:

  • Transmitters & Receivers
  • Sensors
  • Insulin Pumps

By End-Use:

  • Hospitals
  • Homecare Diagnostics

Continuous Glucose Monitoring Market Geographical Analysis:

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • United Kingdom
    • Spain
    • Germany
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia
    • Singapore
    • Malaysia
    • South Korea
    • New Zealand
    • Rest of APAC
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of LATAM
  • Middle East and Africa
    • Middle East
    • Africa

Key Players in the Market:

Major Key Players in the Global Continuous Glucose Monitoring Market

  • Roche Diagnostics
  • Dexcom Inc.
  • Medtronic Inc.
  • Animas corporation
  • Novo Nordisk
  • Ypsomed AG
  • GlySens Incorporated
  • Abbott Laboratories
  • Hoffmann-La Roche Ltd
  • Senseonics Holdings, Inc.
  • Menarini Diagnostics Ltd
  • Echo Therapeutics, Inc
  1. Preface

1.1 Market Definition and Scope

1.2 Base Currency, Base Year and Forecast Periods

1.3 Key Research Objectives

1.4 Research Highlights

  1. General Study Assumptions
  2. Research Methodology

3.1 Introduction

3.2 Secondary Research

3.3 Primary Research

3.4 Analysis Design

3.5 Study Timeline

  1. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Market Trends

  1. Supply Chain Analysis
  2. Company Strategy Analysis

6.1 Merger and Acquisition Analysis

6.2 Agreements, Collaborations and Joint Ventures

6.3 Regional Presence

6.4 New Product Launches

  1. Market Outlook

7.1 Technological Advancement

7.2 Pricing Analysis

7.3 Epidemiology

7.4 Product Landscape Analysis (Brand Tracking Analysis & Pipeline Analysis)

  1. Market Segmentation

8.1 Overview

8.2 Continuous Glucose Monitoring Market, By Component, forecast year 2021-2026

8.2.1 Transmitters & Receivers

8.2.2 Sensors

8.2.3 Insulin Pumps

8.2.4 Market Size Estimations & Forecasts (2021-2026)

8.3.5 Y-o-Y Growth Analysis

8.3.6 Market Investment Opportunities Analysis

8.3 Continuous Glucose Monitoring Market, By End-Use, forecast year 2021-2026

8.3.1 Hospitals

8.3.2 Homecare Diagnostics

8.3.3 Market Size Estimations & Forecasts (2021-2026)

8.3.4 Y-o-Y Growth Analysis

8.3.5 Market Investment Opportunities Analysis

  1. Global Market Regional and Country Analysis, Forecast 2021-2026

9.1 Overview

9.2 Regional Trends

9.3 Impact Analysis

9.4 Key Findings

9.5 Continuous Glucose Monitoring Market,  by Region, 2021-2026

9.5.1 By Component

9.5.2 By End-Use

  1. Competitive Landscape Analysis

10.1 Market Player

10.1.1 Company Revenue

10.1.2 Business unit

10.1.3 Product Mapping

10.1.4 Geographical Locations

10.2 Company Share Analysis

  1. Strategic Analysis

11.1 PESTLE analysis

11.2 Porter’s Five analysis

11.2.1 Bargaining Power of Suppliers

11.2.2 Bargaining Power of Consumers

11.2.3 Threat of New Entrants

11.2.4 Threat of Substitute Products and Services

11.2.5 Competitive Rivalry within the Industry

  1. Company Profiles

12.1 Roche Diagnostics

12.1.1 Overview

12.1.2 Product Portfolio

12.1.3 Financial Details

12.1.4 SWOT Analysis

12.1.5 Market Strategies

12.2 Dexcom Inc.

12.3 Medtronic Inc.

12.4 Animas corporation

12.5 Novo Nordisk

12.6 Ypsomed AG

12.7 GlySens Incorporated

12.8 Abbott Laboratories

12.9 Hoffmann-La Roche Ltd

12.10 Senseonics Holdings, Inc.

12.11 Menarini Diagnostics Ltd

12.12 Echo Therapeutics, Inc

  1. Market Guidance
  2. Appendix